- Home
- BMEA vs TNYA Comparison
BMEA vs TNYA Comparison
Compare BMEA & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMEA
- TNYA
- Stock Information
- Founded
- BMEA 2017
- TNYA 2016
- Country
- BMEA United States
- TNYA United States
- Employees
- BMEA N/A
- TNYA N/A
- Industry
- BMEA Biotechnology: Pharmaceutical Preparations
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- BMEA Health Care
- TNYA Health Care
- Exchange
- BMEA Nasdaq
- TNYA Nasdaq
- Market Cap
- BMEA 153.3M
- TNYA 138.1M
- IPO Year
- BMEA 2021
- TNYA 2021
- Fundamental
- Price
- BMEA $4.19
- TNYA $1.67
- Analyst Decision
- BMEA Buy
- TNYA Strong Buy
- Analyst Count
- BMEA 13
- TNYA 4
- Target Price
- BMEA $37.25
- TNYA $17.33
- AVG Volume (30 Days)
- BMEA 1.1M
- TNYA 7.5M
- Earning Date
- BMEA 10-29-2024
- TNYA 11-06-2024
- Dividend Yield
- BMEA N/A
- TNYA N/A
- EPS Growth
- BMEA N/A
- TNYA N/A
- EPS
- BMEA N/A
- TNYA N/A
- Revenue
- BMEA N/A
- TNYA N/A
- Revenue This Year
- BMEA N/A
- TNYA N/A
- Revenue Next Year
- BMEA N/A
- TNYA N/A
- P/E Ratio
- BMEA N/A
- TNYA N/A
- Revenue Growth
- BMEA N/A
- TNYA N/A
- 52 Week Low
- BMEA $3.61
- TNYA $0.99
- 52 Week High
- BMEA $20.21
- TNYA $7.01
- Technical
- Relative Strength Index (RSI)
- BMEA 24.17
- TNYA 37.59
- Support Level
- BMEA $3.81
- TNYA $0.99
- Resistance Level
- BMEA $6.06
- TNYA $3.69
- Average True Range (ATR)
- BMEA 0.56
- TNYA 0.40
- MACD
- BMEA -0.14
- TNYA -0.27
- Stochastic Oscillator
- BMEA 7.40
- TNYA 22.59
About BMEA Biomea Fusion Inc.
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.